Skip to search.
 TSX Up 0.36% TSX Ventures Up 0.60%

Delcath Systems, Inc. (DCTH)

-NasdaqCM
3.13 Down 0.38(10.83%) 3:51PM EDT
Prev Close:3.51
Open:3.50
Bid:0.02 x 10000
Ask:14.62 x 900
1y Target Est:16.00
Beta:1.29474
Earnings Date:Aug 3 - Aug 8 (Est.)
Day's Range:3.01 - 3.50
52wk Range:3.01 - 10.88
Volume:45,857
Avg Vol (3m):26,525
Market Cap:4.72M
P/E (ttm):N/A
EPS (ttm):-10.82
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
DCTHDown 10.83%4.72M
LLYUp 0.13%86.63B
PFEUp 0.14%223.37B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):3.16
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-7.84
Quarterly EPS Est (Jun-16) :-2.08
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):-0.03

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Delcath Systems, Inc. operates as a specialty pharmaceutical and medical device company focusing on cancers of the liver. The company is developing its proprietary product-Melphalan Hydrochloride for injection for use with the Delcath Hepatic Deli... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback